Paolo Raggi Selected Research

Sevelamer (RenaGel)

10/2016	Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: a substudy of the Renagel in new dialysis trial.
1/2010	Ten-year experience with sevelamer and calcium salts as phosphate binders.
5/2005	Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
5/2005	Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
6/2004	Determinants of progressive vascular calcification in haemodialysis patients.
1/2004	Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
9/2003	The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients.
7/2002	Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Raggi Research Topics

Disease

45	Atherosclerosis 02/2020 - 02/2002
38	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 02/2002
27	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 02/2002
17	Diabetes Mellitus 01/2021 - 05/2004
17	Inflammation (Inflammations) 01/2021 - 05/2005
17	Myocardial Infarction 11/2020 - 02/2002
16	Chronic Renal Insufficiency 02/2020 - 01/2007
16	Vascular Calcification 01/2017 - 02/2002
15	Rheumatoid Arthritis 06/2021 - 12/2007
11	Hypertension (High Blood Pressure) 09/2013 - 07/2005
10	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 11/2005
9	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 02/2002
8	Atherosclerotic Plaque (Atheroma) 03/2019 - 01/2002
7	Ischemia 01/2021 - 07/2006
7	Insulin Resistance 01/2018 - 07/2008
7	Secondary Hyperparathyroidism 12/2013 - 05/2005
7	Pathologic Constriction (Stenosis) 06/2010 - 04/2002
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2008 - 01/2005
6	Heart Failure 11/2020 - 09/2008
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 02/2007
5	Renal Insufficiency (Renal Failure) 12/2015 - 01/2007
5	Vascular Diseases (Vascular Disease) 12/2014 - 09/2003
5	Coronary Disease (Coronary Heart Disease) 12/2012 - 09/2003
5	Hyperphosphatemia 01/2010 - 07/2002
3	Heart Diseases (Heart Disease) 01/2022 - 01/2018
3	Obesity 01/2018 - 01/2009
3	Stroke (Strokes) 04/2016 - 05/2006
3	Lipodystrophy 11/2015 - 01/2010
3	HIV Infections (HIV Infection) 04/2012 - 01/2010
3	Chest Pain (Chest Pains) 01/2008 - 01/2007
3	Acute Coronary Syndrome 11/2005 - 10/2003
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 10/2016
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 05/2012
2	Unstable Angina 11/2020 - 01/2020
2	Weight Loss (Weight Reduction) 01/2020 - 10/2016
2	Fibrosis (Cirrhosis) 08/2019 - 10/2016
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2019 - 01/2019
2	Dyslipidemias (Dyslipidemia) 12/2018 - 08/2012
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018 - 08/2008
2	Sudden Death 10/2016 - 11/2002

Drug/Important Bio-Agent (IBA)

66	CalciumIBA 01/2022 - 01/2002
15	MineralsIBA 01/2021 - 02/2002
13	LipidsIBA 07/2019 - 06/2004
11	Phenobarbital (Luminal)FDA Link 01/2018 - 11/2002
10	Interleukin-6 (Interleukin 6)IBA 05/2019 - 03/2006
9	Phosphates (Orthophosphate)IBA 12/2020 - 02/2002
8	Vitamin D FDA LinkGeneric 12/2020 - 01/2009
8	LDL CholesterolIBA 01/2020 - 05/2006
8	CholesterolIBA 01/2018 - 07/2004
8	Sevelamer (RenaGel)FDA Link 10/2016 - 07/2002
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2011
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020 - 07/2005
6	Parathyroid Hormone (Parathormone)IBA 12/2014 - 11/2006
6	Phosphorus (Red Phosphorus)IBA 01/2010 - 02/2002
5	omega-Chloroacetophenone (Mace)IBA 11/2020 - 06/2008
5	oxidized low density lipoproteinIBA 01/2018 - 10/2008
5	HDL CholesterolIBA 12/2016 - 12/2007
5	C-Reactive ProteinIBA 12/2016 - 12/2007
5	CytokinesIBA 03/2014 - 03/2006
5	Inflammation MediatorsIBA 04/2011 - 07/2008
4	Triglycerides (Triacylglycerol)IBA 09/2013 - 01/2009
4	Cinacalcet (Sensipar)FDA Link 01/2013 - 06/2010
4	SaltsIBA 08/2012 - 09/2003
3	calcium phosphateIBA 01/2021 - 07/2002
3	Troponin IIBA 12/2018 - 01/2012
3	Lipoproteins (Lipoprotein)IBA 01/2018 - 10/2008
3	Pharmaceutical PreparationsIBA 01/2018 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 04/2016 - 04/2005
3	AlbuminsIBA 04/2015 - 09/2003
3	OsteoprotegerinIBA 02/2015 - 01/2007
3	HDL LipoproteinsIBA 09/2013 - 10/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009 - 09/2008
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2008 - 01/2005
2	MicroRNAs (MicroRNA)IBA 06/2021 - 10/2015
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2020
2	SNF472IBA 01/2021 - 01/2020
2	AdiponectinIBA 02/2020 - 05/2010
2	AdipokinesIBA 02/2020 - 05/2010
2	LeptinIBA 02/2020 - 05/2010
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2020 - 01/2020
2	Durapatite (Hydroxylapatite)IBA 03/2019 - 04/2005
2	FluoridesIBA 03/2019 - 01/2019
2	TroponinIBA 12/2018 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 11/2009
2	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 02/2018 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2018 - 12/2012
2	Nonesterified Fatty Acids (NEFA)IBA 03/2014 - 12/2011
2	HomocysteineIBA 09/2013 - 04/2011
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2011 - 11/2009
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2010 - 05/2006
2	25-hydroxyvitamin DIBA 01/2009 - 06/2008
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2008 - 07/2008
2	pro-brain natriuretic peptide (1-76)IBA 09/2008 - 07/2008
2	Adenosine (Adenocard)FDA LinkGeneric 08/2008 - 01/2008

Therapy/Procedure

23	Therapeutics 12/2021 - 02/2002
17	Renal Dialysis (Hemodialysis) 01/2021 - 02/2002
4	Kidney Transplantation 12/2015 - 07/2002
4	Art Therapy 01/2014 - 01/2010
2	Drug Therapy (Chemotherapy) 01/2012 - 11/2009
2	Percutaneous Coronary Intervention 03/2009 - 06/2008